Taiwan · Delayed Price · Currency is TWD Dr. Wu Skincare Statistics
Total Valuation
Dr. Wu Skincare has a market cap or net worth of TWD 5.47 billion. The enterprise value is 4.49 billion.
| Market Cap | 5.47B |
| Enterprise Value | 4.49B |
Important Dates
The last earnings date was Sunday, August 10, 2025.
| Earnings Date | Aug 10, 2025 |
| Ex-Dividend Date | Jul 3, 2025 |
Share Statistics
Dr. Wu Skincare has 45.05 million shares outstanding. The number of shares has increased by 0.29% in one year.
| Current Share Class | 45.05M |
| Shares Outstanding | 45.05M |
| Shares Change (YoY) | +0.29% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 25.74% |
| Owned by Institutions (%) | 0.86% |
| Float | 14.99M |
Valuation Ratios
The trailing PE ratio is 14.12.
| PE Ratio | 14.12 |
| Forward PE | n/a |
| PS Ratio | 4.49 |
| PB Ratio | 3.84 |
| P/TBV Ratio | 3.84 |
| P/FCF Ratio | 19.12 |
| P/OCF Ratio | 18.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.91, with an EV/FCF ratio of 15.70.
| EV / Earnings | 11.55 |
| EV / Sales | 3.69 |
| EV / EBITDA | 8.91 |
| EV / EBIT | 9.06 |
| EV / FCF | 15.70 |
Financial Position
The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.81 |
| Quick Ratio | 3.26 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.15 |
| Interest Coverage | 330.42 |
Financial Efficiency
Return on equity (ROE) is 26.30% and return on invested capital (ROIC) is 20.31%.
| Return on Equity (ROE) | 26.30% |
| Return on Assets (ROA) | 16.04% |
| Return on Invested Capital (ROIC) | 20.31% |
| Return on Capital Employed (ROCE) | 33.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.63 |
| Inventory Turnover | 1.79 |
Taxes
In the past 12 months, Dr. Wu Skincare has paid 101.59 million in taxes.
| Income Tax | 101.59M |
| Effective Tax Rate | 20.70% |
Stock Price Statistics
The stock price has decreased by -18.46% in the last 52 weeks. The beta is 0.13, so Dr. Wu Skincare's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -18.46% |
| 50-Day Moving Average | 125.87 |
| 200-Day Moving Average | 140.01 |
| Relative Strength Index (RSI) | 47.60 |
| Average Volume (20 Days) | 101,824 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Wu Skincare had revenue of TWD 1.22 billion and earned 389.13 million in profits. Earnings per share was 8.60.
| Revenue | 1.22B |
| Gross Profit | 854.65M |
| Operating Income | 495.96M |
| Pretax Income | 490.72M |
| Net Income | 389.13M |
| EBITDA | 499.12M |
| EBIT | 495.96M |
| Earnings Per Share (EPS) | 8.60 |
Balance Sheet
The company has 1.02 billion in cash and 41.90 million in debt, giving a net cash position of 979.83 million or 21.75 per share.
| Cash & Cash Equivalents | 1.02B |
| Total Debt | 41.90M |
| Net Cash | 979.83M |
| Net Cash Per Share | 21.75 |
| Equity (Book Value) | 1.43B |
| Book Value Per Share | 31.53 |
| Working Capital | 1.06B |
Cash Flow
In the last 12 months, operating cash flow was 289.92 million and capital expenditures -3.69 million, giving a free cash flow of 286.23 million.
| Operating Cash Flow | 289.92M |
| Capital Expenditures | -3.69M |
| Free Cash Flow | 286.23M |
| FCF Per Share | 6.35 |
Margins
Gross margin is 70.09%, with operating and profit margins of 40.67% and 31.91%.
| Gross Margin | 70.09% |
| Operating Margin | 40.67% |
| Pretax Margin | 40.24% |
| Profit Margin | 31.91% |
| EBITDA Margin | 40.93% |
| EBIT Margin | 40.67% |
| FCF Margin | 23.47% |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 9.05%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 9.05% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 127.34% |
| Buyback Yield | -0.29% |
| Shareholder Yield | 8.65% |
| Earnings Yield | 7.11% |
| FCF Yield | 5.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 26, 2016. It was a forward split with a ratio of 1.5.
| Last Split Date | May 26, 2016 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Dr. Wu Skincare has an Altman Z-Score of 12.54 and a Piotroski F-Score of 5.
| Altman Z-Score | 12.54 |
| Piotroski F-Score | 5 |